LGP welcomes start-up of Reset sponsored WA Psilocybin clinical trial
TechInvest Magazine
by Staff Writers
1M ago
Little Green Pharma Ltd’s (ASX: LGP) psychedelics focused subsidiary Reset Mind Sciences has launched its clinical trial into the efficacy and safety of psilocybin assisted therapy involving family members for patients with treatment resistant major depressive disorder. The clinical Trial, anticipated to take 12 months to complete, builds on the increasing body of research globally into the use of psilocybin to treat depressive related conditions by incorporating key family members into the preparatory and integration therapy sessions that precede and follow the psilocybin administration sess ..read more
Visit website
Lumos signs major development and IP agreements with US-based Hologic
TechInvest Magazine
by Staff Writers
1M ago
Rapid, point-of-care (POC) diagnostic technology developer Lumos Diagnostics Holdings (ASX:LDX) has signed two new agreements with US based women’s health company, Hologic, Inc. Hologic is a leading innovator and diagnostics service provider in women’s health and has engaged Lumos to develop a next generation version of one of Hologic’s leading on-market women’s health products. The two agreements encompass a Development Agreement and an Intellectual Property (IP) Agreement. Under the Development Agreement Lumos is entitled to receive up to US$4.7 million in payments over an 18-24 month timef ..read more
Visit website
AVITA Medical reaches exclusive distribution agreement
TechInvest Magazine
by Staff Writers
1M ago
Commercial-stage regenerative medicine company AVITA Medical (ASX: AVH) has entered into an exclusive multi-year distribution agreement with Stedical Scientific to commercialise PermeaDerm Biosynthetic Wound Matrix in the United States. PermeaDerm is cleared by the Food and Drug Administration as a transparent matrix for use in the treatment of a variety of wound types until healing is achieved. Under the terms of the agreement, AVITA Medical will hold the exclusive rights to market, sell, and distribute PermeaDerm products, including any future enhancements or modifications, within the Unite ..read more
Visit website
Emyria granted authorised prescriber status for MMDA treatment
TechInvest Magazine
by Staff Writers
1M ago
Mental health and select neurological health treatment developer Emyria Limited’s (ASX: EMD) distinguished psychiatry specialist has been granted “Authorised Prescriber” status by the Therapeutic Goods Administration (TGA). The authorisation enables the prescribing of MDMA according to an ethics committee endorsed care model developed by Emyria and within the strict regulatory framework established by the TGA for the treatment of Post-Traumatic Stress Disorder (PTSD). This authorisation demonstrates Emyria’s commitment to evaluating emerging treatments within the strict regulatory framework ..read more
Visit website
BluGlass secures first order of alpha GaN DFB lasers
TechInvest Magazine
by Staff Writers
1M ago
Global semiconductor developer BluGlass Limited (ASX: BLG) has secured its first purchase order of alpha gallium nitride (GaN) Distributed Feedback (DFB) lasers. The customer is a pioneer in photonic and fiber-based laser technology, and will use BluGlass’ blue prototype DFB lasers in the development of cutting-edge defence, aviation, and scientific applications. Quantum sensing, navigation, and computing applications are driving significant demand for compact single- frequency laser light sources, such as GaN DFB lasers. Single frequency visible lasers have unique characteristics required to ..read more
Visit website
Talius celebrates strong start to 2024
TechInvest Magazine
by Staff Writers
1M ago
Technology enabled care solutions provider Talius Group (ASX: TAL) has executed a Letter of Intent (LOI) with Hato Hone St John in New Zealand for the supply of emergency response systems and related software for use in its telecare business. Hato Hone St John New Zealand is a major health service provider in New Zealand. It provides 90% of the emergency and non-emergency ambulance coverage for the New Zealand population, emergency care and first aid at public events, support phone lines for the elderly and house-bound, hospital patient transport, public first aid training, and health. They a ..read more
Visit website
Li-S demonstrates its Phase 3 2MWh battery production facilities
TechInvest Magazine
by Staff Writers
1M ago
Australian battery technology company Li-S Energy (ASX: LIS) has confirmed that commissioning of the manufacturing equipment in its new $10 million Phase 3 2MWh production facility is now well advanced. The facility, in Geelong Victoria, will allow the company to scale up the manufacture of its lithium sulphur and lithium metal batteries, to enable advanced cell performance testing and the delivery of test and trial cells to current and future partners. “Eighteen months ago we made a commitment to scale up our production capability. As we advance the Phase 3 production line commissioning, I a ..read more
Visit website
Vitura adds NVP smoking cessation product
TechInvest Magazine
by Staff Writers
1M ago
Vitura Health Limited (ASX: VIT) is adding prescription only smoking cessation products on CanView in order to support patients in their journey to quit smoking and reduce their dependency on nicotine. These products are also known as nicotine vaping products (NVPs). The Australian government has outlined its plan to eradicate NVPs from the market that are not accessed via a prescription as part of a medical strategy to support patients in ceasing smoking or reducing their dependency on nicotine. From 1 January 2024, the importation of non-prescription disposable NVPs is prohibited, subject t ..read more
Visit website
1414 Degrees to enhance reactor technology with SiBrick integration
TechInvest Magazine
by Staff Writers
1M ago
Clean energy company 1414 Degrees Ltd (ASX: 14D) has obtained an exclusive licence for a new fluid reactor technology developed and patented by The University of Adelaide. The novel reactor design features innovative dual bubble column technology with liquid metal catalysts for high temperature reactions. 1414 Degrees plans to integrate its SiBrick silicon thermal storage with the reactor design, primarily for emissions-free hydrogen production through pyrolysis of methane. Integrating SiBrick with the Reactor will allow the use of intermittent renewable energy in the process, which requires ..read more
Visit website
Telix Plans US Registered Public Offering and Listing
TechInvest Magazine
by Staff Writers
1M ago
Melbourne-headquartered biopharmaceutical company Telix Pharmaceuticals Limited (ASX:TLX) has revealed it is considering an initial public offering (IPO) in the USA and listing on the Nasdaq Global Market. The IPO would be based of American Depositary Shares (ADSs) representing the company’s ordinary shares in the US Telix’s ordinary shares will remain listed on the Australian Securities Exchange (ASX), The number of ADSs that may be offered, the number of underlying ordinary shares that may be issued, the price for such instruments and the timing of the offering have not yet been finalized ..read more
Visit website

Follow TechInvest Magazine on FeedSpot

Continue with Google
Continue with Apple
OR